Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitors

Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective Mcl-1 inhibitors and as dual Mcl-1/Bcl-2 inhibitors

US Patent 11760752 · Granted Sep 19, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of extracellular signal-regulated kinase2025
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2025
Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors2023
Aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid 2022
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors2021
Reversal of fosfomycin resistance2021
Small molecule lipid II inhibitors2021
Small molecule lipid II inhibitors2021
Small molecule inhibitors of the MCL-1 oncoprotein and uses thereof2020
Potent analogues of the C-Myc inhibitor 10074-G5 with improved cell permeability2016
Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK)2015
Amphipathic and other double-sided alpha-helix mimetics based on a 1,2-diphenyla2014